| 注册
首页|期刊导航|中国实用内科杂志|脂代谢异常与胸腺相关疾病的关系及临床干预策略

脂代谢异常与胸腺相关疾病的关系及临床干预策略

李群浩 高聆

中国实用内科杂志2026,Vol.46Issue(8):641-648,8.
✕
中国实用内科杂志2026,Vol.46Issue(8):641-648,8.DOI:10.19538/j.nk2026080104

脂代谢异常与胸腺相关疾病的关系及临床干预策略

Relationship between abnormal lipid metabolism and thymus-related diseases and the clinical intervention strategies

李群浩 1高聆2

作者信息

  • 1. 内分泌糖脂代谢与脑老化教育部重点实验室 山东第一医科大学附属省立医院内分泌代谢病科,山东济南 250021
  • 2. 山东省立医院科研中心,山东济南 250021
  • 折叠

摘要

Abstract

Abnormal lipid metabolism has emerged as a major clinical challenge threatening the body's metabolic and immune homeostasis.The subsequent imbalance of the"immune-metabolic axis"serves as the pathological foundation for the occurrence and development of thymus-related diseases.Intra-thymic lipid deposition not only drives premature fatty involution of the thymus and the disruption of central immune tolerance,but is also a core mechanism that induces the malignant invasion of thymic epithelial tumors(TETs)and exacerbates the severity of myasthenia gravis(MG).This article focuses on the relationship between abnormal lipid metabolism and thymus-related diseases,elaborating on a multi-target intervention strategy centering on lipid regulation,combined with weight management,novel dual-target metabolic modulators,peroxisome proliferator-activated receptor(PPAR)agonists,PCSK9 inhibitors,and gut microbiome nutrition.By reducing lipotoxicity to repair target organs and restore immune homeostasis,this strategy aims to break through the bottlenecks of traditional therapies,providing a novel perspective for the diagnosis,treatment and management of thymus-related diseases.

关键词

脂代谢异常/胸腺疾病/免疫-代谢轴/胸腺上皮肿瘤/重症肌无力

Key words

abnormal lipid metabolism/thymus diseases/immune-metabolic axis/thymic epithelial tumors/myasthenia gravis

分类

医药卫生

引用本文复制引用

李群浩,高聆..脂代谢异常与胸腺相关疾病的关系及临床干预策略[J].中国实用内科杂志,2026,46(8):641-648,8.

基金项目

山东省重点研发计划(2024CXPT088) (2024CXPT088)

中国实用内科杂志

1005-2194

访问量0
|
下载量0
段落导航相关论文